Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2

Pharmacology, Toxicology and Pharmaceutical Science

• Hemin 100%
• Imatinib 90%
• Heme 50%
• Element 30%
• Leukemia 30%
• IC50 20%
• Anthracycline 20%
• Protein 10%
• Reagent 10%
• Phosphotransferase 10%
• RNA 10%
• Heme Oxygenase 1 10%
• Synthetase 10%
• Aminolevulinic Acid 10%
• Mitoxantrone 10%
• Doxorubicin 10%
• Drug Resistance 10%
• Daunorubicin 10%
• Succinylacetone 10%
• Antileukemic Agent 10%
• Idarubicin 10%
• Apoptosis 10%

Biochemistry, Genetics and Molecular Biology

• Imatinib 90%
• Recognition 40%
• IC50 20%
• Nested Gene 10%
• Gene Promoter 10%
• Kinase 10%
• Cell Function 10%
• Heme Oxygenase 10%
• Precursor 10%
• Apoptosis 10%
• Heme Synthesis 10%
• Doxorubicin 10%
• Drug Resistance 10%
• RNA Interference 10%
• Light 10%
• Dose 10%
• Contrast 10%
• Protein 10%
• Aptitude 10%
• Daunorubicin 10%
• Idarubicin 10%

Veterinary Science and Veterinary Medicine

• Doxorubicin 10%